The Blood & Tissue Center Foundation
The April 2026 Blood & Tissue Center Foundation Board meeting was a powerful reminder of our purpose, as new board members Alex Menchaca and Michelle Robles-Menchaca shared the story of
The 2026 Foundation Chairs, Kristen Schneider Boerger and Morgan Bertram, bring deep personal conviction and years of service to The Blood & Tissue Center Foundation. In this Q&A, they share what inspired them to join, why they stepped into leadership, and what they hope to accomplish in the year ahead.
Building on the success of the 2025 Red & White Ball, the goal for this year’s ball will be “funding the mission of BioBridge Global,” Foundation Executive Director Jay Podjenski shared with members of the board at its first meeting of 2026.
The 2026 Foundation Chairs, Kristen Schneider Boerger and Morgan Bertram, share their vision for momentum, leadership, and continued impact at The Blood & Tissue Center Foundation. Dear Board of Directors,
On Oct. 16, The Foundation was honored to host the Valero Texas Open (VTO) Trailblazers for their monthly meeting and a special tour of our facilities. The visit was made possible by
The fundraising focus of last year’s Red & White Ball, as well as this year’s, were major topics at the latest quarterly meeting of The Blood & Tissue Center Foundation
We’re thrilled to welcome Chris Callaway to the board. Chris was nominated by Stephanie Stephens following a tour in June and brings with him over 30 years of leadership experience
South Texas Blood & Tissue received a heartfelt welcome from Live Oak and neighboring cities on Wednesday for the official ribbon cutting of the Northeast Donor Center. Councilmen, young professionals,
The May 5 Blood & Tissue Center Foundation Board meeting saw a strong turnout of longtime board members eager to celebrate more than 15 years of dedicated service by Foundation
Proceeds from the 2025 Red & White Ball will help build capacity in an area of historic interest for The Blood & Tissue Center Foundation – supporting new cures for cancer and other serious conditions – the board of directors decided at their meeting Monday.
